Vivos Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Vivos Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $-0.40 | $-0.70 | 42.9 % |
Jun 2024 | 2024-08-14 | $-0.60 | $-1.05 | 42.9 % |
Dec 2023 | 2024-03-28 | $-3.05 | $-1.90 | -60.5 % |
Jun 2023 | 2023-08-16 | $-4.50 | $-3.50 | -28.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $3.86M | $4.18M | -7.66 % |
Jun 2024 | 2024-08-14 | $4.05M | $3.60M | 12.6 % |
Dec 2023 | 2024-03-28 | $3.25M | $3.41M | -4.75 % |
Jun 2023 | 2023-08-16 | $3.40M | $4.15M | -18.2 % |
Vivos Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3.
Vivos Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was $-0.40, which beat the estimate of $-0.70.
Vivos Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which missed the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.